Tuberculosis (TB) cases in England increased by 13.6% in 2024 compared with the previous year, according to new data from the UK Health Security Agency (UKHSA). There were 5490 TB notifications in ...

According to the DataM Intelligence: The global tuberculosis drug market size reached US$ 2.34 Billion in 2023 with a rise of US$ 2.45 Billion in 2024 and is expected to reach US$ 3.78 Billion by 2033 ...

Life-saving treatments for newborns suffering from sepsis are becoming dangerously ineffective across Southeast Asia, according to new research, with experts warning that drug-resistant bacteria are ...

Health experts in Kigezi Sub-region have attributed the rise in Multi-Drug Resistant (MDR) Tuberculosis (TB) cases to poor drug adherence and are calling for multi-sectoral interventions to reduce the ...

The voices of drug-resistant tuberculosis survivors are a stark reminder that behind every statistic lies a human being enduring immense suffering. Their appeal for shorter, all-oral and safer ...

After an initial treatment response, most ovarian cancers recur because of drug-resistant cell populations. Blood-based tracking, used to monitor clonal evolution in 18 patients, shows that ...

Difficult-to-treat infections caused by dangerous, drug-resistant bacteria are on an alarming upward climb, the Centers for Disease Control and Prevention warned in a recent health alert. Known ...